Kallus; Christopher

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kallus; Christopher.The latest application filed is for "macrocyclic urea and sulfamide derivatives as inhibitors of tafia".

Company Profile

0.16.14

Kallus; Christopher - Frankfurt am Main DE
Kallus; Christopher - Frankfurt DE
Kallus; Christopher - Mainz DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals Grant 9,834,527 - Evers , et al. December 5, 2	2017-12-05
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 9,688,645 - Kallus , et al. June 27, 2	2017-06-27
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20160251324 - KALLUS; Christopher ; et al.	2016-09-01
Macrocyclic Urea Derivatives as Inhibitors of TAFIa, Their Preparation and Their Use as Pharmaceuticals App 20160137618 - Evers; Andreas ; et al.	2016-05-19
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 9,309,207 - Kallus , et al. April 12, 2	2016-04-12
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20160024033 - KALLUS; Christopher ; et al.	2016-01-28
Biaryl-propionic acid derivatives and their use as pharmaceuticals Grant 9,199,947 - Ruf , et al. December 1, 2	2015-12-01
Biaryl-propionic acid derivatives and their use as pharmaceuticals Grant 9,150,526 - Ruf , et al. October 6, 2	2015-10-06
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 9,126,955 - Kallus , et al. September 8, 2	2015-09-08
Biaryl-propionic acid derivatives and their use as pharmaceuticals App 20140296239 - Ruf; Sven ; et al.	2014-10-02
Biaryl-Propionic Acid Derivatives and their Use as Pharmaceuticals App 20140296296 - Ruf; Sven ; et al.	2014-10-02
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20140206760 - Kallus; Christopher ; et al.	2014-07-24
Macrocyclic urea and sulfamide derivatives as inhibitors of tafia Grant 8,722,655 - Kallus , et al. May 13, 2	2014-05-13
Imidazole derivatives used as TAFIa inhibitors Grant 8,710,232 - Kallus , et al. April 29, 2	2014-04-29
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20140039011 - Kallus; Christopher ; et al.	2014-02-06
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 8,580,777 - Kallus , et al. November 12, 2	2013-11-12
Urea and sulfamide derivatives as inhibitors of TAFIa Grant 8,389,764 - Kallus , et al. March 5, 2	2013-03-05
Imidazole derivatives as inhibitors of TAFIa Grant 8,044,208 - Kallus , et al. October 25, 2	2011-10-25
MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa App 20110178130 - Kallus; Christopher ; et al.	2011-07-21
UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa App 20100035930 - KALLUS; Christopher ; et al.	2010-02-11
Imidazole Derivatives As Inhibitors Of Tafia App 20080262028 - KALLUS; Christopher ; et al.	2008-10-23
Imidazole Derivatives Used As Tafia Inhibitors App 20070129341 - Kallus; Christopher ; et al.	2007-06-07
Tetrahydroquinoxalines acting as bradykinin antagonists App 20040235849 - Beyreuther, Bettina ; et al.	2004-11-25
Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same Grant 6,756,489 - Schmidt , et al. June 29, 2	2004-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.